The Impella 2.5® and Impella CP® devices are U.S. FDA approved to treat certain advanced heart failure patients undergoing elective and urgent percutaneous coronary interventions (PCI), such as ...

Doctors at Abrazo West Campus saved Deanna Morehead with the world's smallest heart pump after a heart attack.

The U.S. FDA posted notice of a medical device correction of Abiomed Inc.'s Impella series of left-side blood pumps because of the risk of perforation of the left ventricle during device placement.

WASHINGTON, DC—In the DanGer Shock trial of Impella CP (Abiomed) in patients with STEMI complicated by cardiogenic shock (STEMI-CS), bleeding occurs not just in the cath lab but also while on ...

Among 355 patients who were included in the analysis, 58.5% of those who received standard care alone and 45.8% of those who received the Impella pump had died at six months after randomization ...

Neibart noted that other advances, like the Impella medical device – which pulls blood from the ventricle and pushes it out into the aorta, delivering oxygen-rich blood to the rest of the ...

The study demonstrated Impella ECP’s safety and efficacy for use in high-risk PCI. Operators chose 8Fr Angio-Seal as the first-closure method in 70% of the patients, with a 92% success rate [1].

Johnson & Johnson halved its expectations for costs this year related to new tariffs and raised its full-year sales and ...

The Impella CP promises a substantial amount of cardiac power, can be inserted quickly, and is ideal for patients that require more hemodynamic support,” said John Lasala M.D., medical director ...